shutterstock_1653845269_taljat_david
Taljat David / Shutterstock.com
23 May 2023Big PharmaSarah Speight

Novartis ‘abused’ discovery process for Zolgensma patent

Two subsidiaries of French pharmaceutical giant Sanofi have accused rival Novartis of abusing the discovery process in a previous lawsuit, concerning royalties from a gene therapy treatment for spinal muscular atrophy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
18 April 2023   Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel.
Big Pharma
17 January 2023   The pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP.

More on this story

Americas
18 April 2023   Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel.
Big Pharma
17 January 2023   The pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP.

More on this story

Americas
18 April 2023   Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel.
Big Pharma
17 January 2023   The pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP.